tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Similar Stocks

Compare
255 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Gain Therapeutics
$2.27
$62.07M
-48.64%
2 Buy
0 Hold
0 Sell
Moderate Buy
Amicus
$9.19
$2.79B
-32.23%
7 Buy
3 Hold
0 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$42.59
$4.11B
-11.60%
15 Buy
1 Hold
0 Sell
Strong Buy
Blueprint Medicines
$92.25
$6.03B
5.72%
11 Buy
4 Hold
0 Sell
Moderate Buy
Oric Pharmaceuticals
$7.68
$530.57M
-30.31%
9 Buy
0 Hold
0 Sell
Strong Buy
Pliant Therapeutics
$3.08
$183.17M
-80.57%
5 Buy
7 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
GANX
Gain Therapeutics
2.27
-2.28
-50.11%
FOLD
Amicus
9.19
-4.34
-32.08%
RARE
Ultragenyx Pharmaceutical
42.59
-6.89
-13.92%
BPMC
Blueprint Medicines
92.25
2.76
3.08%
ORIC
Oric Pharmaceuticals
7.68
-3.34
-30.31%
PLRX
Pliant Therapeutics
3.08
-13.35
-81.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis